“Well, guess what? The big calamity? It never materialized,” Cramer said. “We overestimated the prowess of Amazon in the auto parts space and we underestimated the power of AutoZone.”

Until recently, shares of CVS exhibited a similar pattern. As the drugstore operator prepared to merge with Aetna, investors worried that Amazon’s moves in the pharmaceutical and health care spaces would encroach on the deal’s potential.

But after CVS’ better-than-expected second-quarter earnings report, “I think we’ve given Amazon too much credit and CVS too little,” Cramer said. “As powerful as the Death Star may be, it can’t wipe out a whole industry overnight.”

For more on why investors should have faith in particular companies including Disney, click here.

Smart speaker maker Sonos may have come public earlier this month to significant fanfare, but Cramer had some reservations after reviewing the company’s business model.

With high-end wireless and voice-enabled speakers on its product list, Sonos’ key selling point is its repeat business: 37 percent of its new product registrations in 2017 came from existing customers.

But as consumer technology becomes more durable, Cramer worried that Sonos’ recurring business could eventually become saturated: how often will customers really need to replace their costly speaker systems?

Sonos’ business, which has produced conflicting results quarter to quarter and is further complicated by its ties to Amazon, reminded Cramer of a not-so-hot name he once backed: Fitbit.

Short-sellers might be rigorous in their methods, but Tesla CEO Elon Musk hasn’t made it easy to short the stock of his automaker, Cramer said Wednesday.

“There are four fundamental problems that make shorting stocks especially dangerous, problems that are bedeviling these professional pessimists as they confront perhaps the greatest short-buster in modern memory, … Elon Musk,” Cramer said.

Musk’s $420-a-share price target showed “why it’s so tough to bet against individual companies,” Cramer argued, turning to the first flaw: the notion that Musk did something wrong by opining on his company’s future.

Consumer spending on health care for their pets is undoubtedly on the rise. Now, Idexx Laboratories, a leading player in the veterinary tech and diagnostics, is bringing a new type of treatment to the mix: preventative care.

“We see preventative care, including bloodwork, as one of the major long-term growth drivers,” Idexx Chairman and CEO Jonathan Ayers told Cramer in a Wednesday interview.

Ayers said when veterinarians run blood work on healthy, adult dogs, there is a one-in-seven chance that they find “significant underlying disease.”

“[Pets] can’t tell you how they feel, and so the diagnostics is sort of the voice of the pet,” Ayers told Cramer. “And what our innovation does is it expands their vocabulary so they can tell us more about their health status.”

Cramer also took an interest in the performance of shares of CarMax and AutoNation, two competing car dealers with totally divergent stock paths.

Since the start of 2018, shares of CarMax have gained 17 percent, beating the S&P 500’s performance, but AutoNation’s stock has sunk 7 percent.

“They’re both big auto dealership chains with hundreds of locations, they both sell new and used vehicles, so how the heck has the stock of CarMax been able to leave the stock of AutoNation in the dust?” Cramer wondered.

The answer boiled down to their businesses. While the two companies look similar on the surface, they are differently structured, with CarMax focusing primarily on used cars and AutoNation raking in twice as much revenue from new cars as used ones.

Therefore, as tariffs on steel and aluminum boosted prices on cars and car parts, AutoNation ate those costs while CarMax profited from selling its lower-tax used cars.

“No wonder CarMax is wiping the floor with AutoNation,” the “Mad Money” host said. “The bottom line? At the beginning of the year, I told you to avoid AutoNation’s stock and stick with the better-run, used-car-vehicle heavy CarMax. That’s been a good call, and, if anything, things are looking even better for CarMax here, especially since its stock remains darned cheap, selling for just 15 times next year’s earnings estimates.”

Enable Midstream Partners: “It does qualify as a dividend play. Now, when you get those, you remember I like Enterprise. This has been a very challenged group. I like Magellan Midstream. I screwed up on that one for ActionAlerts. My problem is this: you have to understand that the group’s just had a big move and it’s going to cool off because Energy Transfer Partners did not have good numbers, so be careful.”

Eagle Materials Inc.: “No. This is a very challenged group right now. by the way, this whole sector that involves construction I’m getting a little cooler on, so I’m going to say no to that one. Sorry.”

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

You can adjust all of your cookie settings by navigating the tabs on the left hand side.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

disable

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.